Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Erypnos 10000IU/ml Injection

Prescription Icon
Prescription Required

Marketer

Akognos Life Sciences

Salt Composition

Recombinant Human Erythropoietin Alfa (10000IU/ml)

Overview Erypnos 10000IU/ml Injection

Epoetin alfa 10000IU/ml Injection stimulates red blood cell production in the bone marrow. This medication treats anemia resulting from chronic kidney disease, cancer chemotherapy, or HIV medications. Administered subcutaneously or intravenously (as determined by your physician), it's typically injected by a healthcare professional. Dosage is weight-based and tailored to the underlying cause of anemia. Concurrent iron supplementation may enhance efficacy. Store refrigerated, but allow to reach room temperature before use. Common side effects include nausea, vomiting, fever, and elevated blood pressure; flu-like symptoms (headache, fatigue, dizziness, myalgia) are also possible, often subsiding with continued treatment. Persistent side effects should be reported to your doctor. Seek immediate medical attention for serious adverse events, including seizures. Serious thromboembolic events are a potential risk. Inform your doctor of uncontrolled hypertension, heart conditions, or gout before initiating treatment, and disclose all other medications. Regular blood pressure monitoring and laboratory tests are necessary. The effects on pregnancy are unknown; inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

Primary Ingredients of Erypnos 10000IU/ml Injection

No information provided. Please provide the text you wish me to rephrase.

Uses of Erypnos 10000IU/ml Injection

Managing anemia resulting from cancer treatments or chronic kidney failure.

Major Benefits of Erypnos 10000IU/ml Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Erypnos 10000IU/ml Injection:

  • High blood pressure
  • Nausea
  • Vomiting
  • Fever
  • Rash
  • Joint pain
  • Headache
  • Insomnia (difficulty in sleeping)
  • Chills
  • Cough
  • Bone pain
  • Muscle spasm
  • Dizziness
  • Vascular occlusion
  • Injection site irritation
  • Stomatitis (Inflammation of the mouth)
  • Weight loss
  • Decreased white blood cell count (lymphocytes)
  • Increased glucose level in blood
  • Blood clot in the blood vessels

How to use Erypnos 10000IU/ml Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Erypnos 10000IU/ml Injection works:

Erypnos 10000 IU/ml Injection, a medication classified as an erythropoiesis-stimulating agent (ESA), enhances red blood cell production. It achieves this by activating the bone marrow—the blood cell-generating tissue within bones—to increase red blood cell output.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of alcohol consumption while using Erypnos 10000IU/ml Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Erypnos 10000IU/ml Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Erypnos 10000IU/ml Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

The injectable medication Erypnos (10,000 IU/ml) may produce adverse reactions that could impair driving ability.

KidneyKidneySAFE IF PRESCRIBED

For patients with kidney disease, Erypnos 10000IU/ml Injection is considered safe and requires no dosage modification. However, routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Administering Erypnos 10000IU/ml Injection requires careful consideration in individuals with hepatic impairment. Dosage modifications for Erypnos 10000IU/ml Injection may be necessary. Physician consultation is advised.

What if you forget to take Erypnos 10000IU/ml Injection :

Omit Erypnos 10000IU/ml Injection doses should prompt immediate physician consultation.

Facts to Know About Erypnos 10000IU/ml Injection

LabelValue
Chemical Classification Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Erypnos 10000IU/ml Injection

Hospital-stored Erypnos 10000IU/ml pre-filled syringes remain unopened and refrigerated (2-8°C). Home storage requires refrigeration (not freezing). Before use, allow the syringe to reach room temperature (15-30 minutes). Syringes in use or soon to be used may remain at room temperature (below 25°C) for up to 7 days. Keep out of reach of children and protected from light.
Inform your doctor or nurse immediately if you suspect an overdose of Erypnos 10000IU/ml Injection.
Do not use Erypnos 10000IU/ml Injection if the solution is cloudy, contains particles, or is expired (check the label). Avoid use if you suspect freezing or refrigerator malfunction.
Erypnos 10000IU/ml Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults.
Yes, Erypnos 10000 IU/ml Injection can influence blood pressure. Close blood pressure monitoring is essential during initial treatment. Patients with hypertension should manage their blood pressure accordingly. The doctor may discontinue Erypnos 10000 IU/ml Injection if blood pressure remains unmanaged.
Erypnos 10000IU/ml Inject...
2,087
MRP 2,300
9% off